Literature DB >> 23786524

Mutual regioselective inhibition of human UGT1A1-mediated glucuronidation of four flavonoids.

Guo Ma1, Baojian Wu, Song Gao, Zhen Yang, Yong Ma, Ming Hu.   

Abstract

UDP-glucuronosyltransferase (UGT) 1A1-catalyzed glucuronidation is an important elimination pathway of flavonoids, and mutually inhibitory interactions may occur when two or more flavonoids are coadministered. Our recent research suggested that glucuronidation of flavonoids displayed distinct positional preferences, but whether this will lead to the mutually regioselective inhibition of UGT1A1-mediated glucuronidation of flavonoids is unknown. Therefore, we chose three monohydroxyflavone isomers, 3-hydroxyflavone (3HF), 7-hydroxyflavone (7HF), and 4'-hydroxyflavone (4'HF), and one trihydroxyflavone, 3,7,4'-trihydroxyflavone (3,7,4'THF), as the model compounds to characterize the possible mutually regioselective inhibition of glucuronidation using expressed human UGT1A1. Apparent kinetic parameters [e.g., reaction velocity (V), Michaelis-Menten constant (Km), maximum rate of metabolism (Vmax), concentration at which inhibitor achieves 50% inhibition (IC50), and the Lineweaver-Burk plots were used to evaluate the apparent kinetic mechanisms of inhibition of glucuronidation. The results showed that UGT1A1-mediated glucuronidation of three monohydroxyflavones (i.e., 3HF, 7HF, and 4'HF) and 3,7,4'THF was mutually inhibitory, and the mechanisms of inhibition appeared to be the mixed-typed inhibition. Specifically, the inhibitory effects displayed certain positional preference. Glucuronidation of 3HF was more easily inhibited by 3,7,4'THF than that of 7HF or 4'HF. Compared to 7-O-glucuronidation of 3,7,4'THF, 3-O-glucuronidation of 3,7,4'THF was more inhibited by 3HF and 4'HF, whereas glucuronidation at both 3-OH and 7-OH positions of 3,7,4'THF was more easily inhibited by 7HF than by 3HF and 4'HF. In conclusion, 3HF, 7HF, 4'HF, and 3,7,4'THF were both substrates and inhibitors of UGT1A1, and they exhibited mutually regioselective inhibition of UGT1A1-mediated glucuronidation via a mixed-type inhibitory mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786524      PMCID: PMC3953455          DOI: 10.1021/mp300599t

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  31 in total

Review 1.  Beyond eyeballing: fitting models to experimental data.

Authors:  A Christopoulos; M J Lew
Journal:  Crit Rev Biochem Mol Biol       Date:  2000       Impact factor: 8.250

2.  Metabolism of flavonoids via enteric recycling: role of intestinal disposition.

Authors:  Jun Chen; Huimin Lin; Ming Hu
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

Review 3.  Recent advances in understanding the antibacterial properties of flavonoids.

Authors:  T P Tim Cushnie; Andrew J Lamb
Journal:  Int J Antimicrob Agents       Date:  2011-04-22       Impact factor: 5.283

4.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

5.  In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Authors:  Donglu Zhang; Theodore J Chando; Donald W Everett; Christopher J Patten; Shangara S Dehal; W Griffith Humphreys
Journal:  Drug Metab Dispos       Date:  2005-08-23       Impact factor: 3.922

6.  Phosphoprotein levels, MAPK activities and NFkappaB expression are affected by fisetin.

Authors:  Roberta R Ruela de Sousa; Karla Cristiana Souza Queiroz; Ana Carolina Santos Souza; Sonia A Gurgueira; Amanda Cavallari Augusto; Marcio André Miranda; Maikel P Peppelenbosch; Carmen Veríssima Ferreira; Hiroshi Aoyama
Journal:  J Enzyme Inhib Med Chem       Date:  2007-08       Impact factor: 5.051

7.  Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.

Authors:  Margalida Rotger; Patrick Taffe; Gabriela Bleiber; Huldrych F Gunthard; Hansjakob Furrer; Pietro Vernazza; Henning Drechsler; Enos Bernasconi; Martin Rickenbach; Amalio Telenti
Journal:  J Infect Dis       Date:  2005-09-09       Impact factor: 5.226

8.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

Review 9.  Dietary flavonoids as antioxidants.

Authors:  Junji Terao
Journal:  Forum Nutr       Date:  2009-04-07

10.  Inhibitory effect of phthalic Acid on tyrosinase: the mixed-type inhibition and docking simulations.

Authors:  Shang-Jun Yin; Yue-Xiu Si; Guo-Ying Qian
Journal:  Enzyme Res       Date:  2011-05-23
View more
  2 in total

1.  Quantitative prediction and clinical evaluation of an unexplored herb-drug interaction mechanism in healthy volunteers.

Authors:  B T Gufford; J T Barr; V González-Pérez; M E Layton; J R White; N H Oberlies; M F Paine
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-11-28

2.  Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1.

Authors:  Xuewei Cheng; Xia Lv; Hengyan Qu; Dandan Li; Mengmeng Hu; Wenzhi Guo; Guangbo Ge; Ruihua Dong
Journal:  Acta Pharm Sin B       Date:  2017-09-01       Impact factor: 11.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.